Infanrix hexa: a hexavalent vaccine for infant immunisation

Abstract

The hexavalent vaccine Infanrix hexa, which protects against hepatitis B in addition to diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b, was introduced to the UK routine infant immunisation schedule in Autumn 2017. This article summarises its efficacy and adverse effects, with an overview of the new immunisation schedule.